Comparison of clomiphene citrate + letrozole add‐on versus classical ovarian stimulation protocols in diminished ovarian reserve patients
Journal of Obstetrics and Gynaecology Research · 2025
DOI: 10.1111/jog.16245 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2025. Verfasst von Mehmet Tunç und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Başkent University Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Letrozole, Clomiphene, Ovulation Induction, Ovarian Reserve. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Aim
To investigate if there is any benefit of adding clomiphene citrate (CC) + letrozole to controlled ovarian stimulation (COS) cycles on the total gonadotropin dose in POSEIDON group 4 diminished ovarian reserve (DOR) patients.
Methods
A total of 61 DOR patients who underwent 150 COS cycles between 2020 and 2023 in our center were investigated retrospectively. The patients were divided into three main subgroups: group A, group B, and group C. In group A, gonadotropin stimulation started after the completion of 5 days of co‐treatment with CC (50 mg twice daily) and letrozole (2.5 mg twice daily). In group B, patients received gonadotropins after completing 5 days of letrozole (2.5 mg twice, daily), and in group C, patients started gonadotropins only.
Results
Mean age was higher in groups A and B. Body mass index, previous parity, and mean AMH levels were similar between the groups. Day 2 antral follicle count was significantly lower in group A (0.90, 1.45 and 1.53; p = 0.017). The need for gonadotropins was lower in group A compared to groups B and C ( p = 0.131, and p = 0.029; respectively). Cycle cancellation rates, follicle count on trigger day, number of mature oocytes, number of cleavage stage embryos, and number of blastocyst stage embryos were similar between the groups.
Conclusion
CC + letrozole co‐treatment before starting gonadotropin stimulation in POSEIDON group 4 DOR patients might reduce the need for gonadotropins, with similar live birth rates in COS cycles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Başkent University Hospital, Ankara, Turkey.
ORCID-Profile: Mehmet Tunç
Zitieren
APA
Tunç, M., & Önalan, G. (2025). Comparison of clomiphene citrate + letrozole add‐on versus classical ovarian stimulation protocols in diminished ovarian reserve patients. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16245
Vancouver
Tunç M, Önalan G. Comparison of clomiphene citrate + letrozole add‐on versus classical ovarian stimulation protocols in diminished ovarian reserve patients. Journal of Obstetrics and Gynaecology Research. 2025. doi:10.1111/jog.16245
BibTeX
@article{Tun2025,
author = {Tunç, Mehmet and Önalan, Göğşen},
title = {Comparison of clomiphene citrate + letrozole add‐on versus classical ovarian stimulation protocols in diminished ovarian reserve patients},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
doi = {10.1111/jog.16245}
}
EUVIMED